| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11033-011-1269-1 |
| P8608 | Fatcat ID | release_wskw2hvrijbrxpclwtnsevlv6y |
| P698 | PubMed publication ID | 21947851 |
| P5875 | ResearchGate publication ID | 51674913 |
| P50 | author | Raj Kumar Duary | Q54678765 |
| P2093 | author name string | Sunita Grover | |
| Virender Kumar Batish | |||
| Mache Amit Bhausaheb | |||
| P2860 | cites work | A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 |
| Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer | Q28218034 | ||
| The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments | Q28236560 | ||
| A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease | Q28254686 | ||
| Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR | Q29400573 | ||
| A key role of dendritic cells in probiotic functionality | Q30830505 | ||
| Oral probiotic control skin inflammation by acting on both effector and regulatory T cells | Q33419855 | ||
| Probiotics and prebiotics in chronic inflammatory bowel diseases | Q34013030 | ||
| Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial | Q34510060 | ||
| Intestinal microflora: probiotics and autoimmunity | Q34575939 | ||
| Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria | Q35140083 | ||
| Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria | Q35595154 | ||
| Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics | Q35787456 | ||
| Probiotics and the management of inflammatory bowel disease. | Q35854517 | ||
| Role of the high affinity immunoglobulin E receptor in bacterial translocation and intestinal inflammation | Q36376117 | ||
| Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants | Q36430535 | ||
| Probiotic effects on inflammatory bowel disease. | Q36740877 | ||
| Therapeutic effects of four strains of probiotics on experimental colitis in mice | Q37122235 | ||
| Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression | Q38442953 | ||
| Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis | Q39909705 | ||
| The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells | Q40231712 | ||
| Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. | Q40725779 | ||
| Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures | Q42018332 | ||
| Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells | Q42093459 | ||
| Modulation of human dendritic cell phenotype and function by probiotic bacteria | Q43004747 | ||
| Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial | Q43363077 | ||
| Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. | Q43746137 | ||
| Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains | Q44851597 | ||
| Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. | Q44930893 | ||
| VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
| Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice | Q59120727 | ||
| Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study | Q63285887 | ||
| Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease | Q72189511 | ||
| Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis | Q73837821 | ||
| Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells | Q77373909 | ||
| Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice | Q77659986 | ||
| Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model | Q78626902 | ||
| Interaction of lactic acid bacteria with the gut immune system | Q78853845 | ||
| The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice | Q81550827 | ||
| P433 | issue | 4 | |
| P921 | main subject | inflammation | Q101991 |
| colitis | Q2453464 | ||
| Lactobacillus plantarum | Q1756682 | ||
| probiotics | Q1816730 | ||
| P304 | page(s) | 4765-4775 | |
| P577 | publication date | 2011-09-23 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | Anti-inflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model | |
| P478 | volume | 39 |
| Q38143713 | A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action |
| Q41328596 | Adhesion of Lactobacilli and their anti-infectivity potential |
| Q39130704 | Adhesion of indigenous Lactobacillus plantarum to gut extracellular matrix and its physicochemical characterization |
| Q47706915 | Anti-arthritic activity of cell wall content of Lactobacillus plantarum in freund's adjuvant-induced arthritic rats: involvement of cellular inflammatory mediators and other biomarkers |
| Q60954933 | Anti-inflammatory and Antioxidant Properties of Probiotic Bacterium AN1 and SNR1 in Wistar Albino Rats |
| Q92723812 | Antimicrobial Effect and Probiotic Potential of Phage Resistant Lactobacillus plantarum and its Interactions with Zoonotic Bacterial Pathogens |
| Q58118981 | Assessing safety of Lactobacillus plantarum MTCC 5690 and Lactobacillus fermentum MTCC 5689 using in vitro approaches and an in vivo murine model |
| Q37272397 | Beneficial Properties of Probiotics. |
| Q41595109 | Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis |
| Q59807332 | Complete Genome Sequencing of ZLP001, a Potential Probiotic That Enhances Intestinal Epithelial Barrier Function and Defense Against Pathogens in Pigs |
| Q28083627 | Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models |
| Q26823069 | Diet, microbiome, and the intestinal epithelium: an essential triumvirate? |
| Q37333918 | Draft Genome Sequence of Lactobacillus plantarum Strain Lp91, a Promising Indian Probiotic Isolate of Human Gut Origin |
| Q55152165 | Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease. |
| Q37092839 | Immunomodulatory Effects of Lactobacillus plantarum Lp62 on Intestinal Epithelial and Mononuclear Cells |
| Q33632901 | Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells |
| Q51377185 | Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. |
| Q37224547 | In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut. |
| Q26751158 | Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links |
| Q39393210 | Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. |
| Q37299999 | Modulation of anti-inflammatory response in lipopolysaccharide stimulated human THP-1 cell line and mouse model at gene expression level with indigenous putative probiotic lactobacilli |
| Q34499067 | Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics |
| Q37643234 | Multistrain probiotic modulation of intestinal epithelial cells' immune response to a double-stranded RNA ligand, poly(i·c). |
| Q57406718 | New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis |
| Q34645833 | Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis |
| Q46488508 | Novel yeast isolated from broilers' feedstuff, gut and faeces as aflatoxin B1 adsorbents |
| Q41005321 | Prevent Effects of Lactobacillus Fermentum HY01 on Dextran Sulfate Sodium-Induced Colitis in Mice |
| Q36531370 | Probiotics for human health -new innovations and emerging trends |
| Q38073062 | Role of endogenous microbiota, probiotics and their biological products in human health |
| Q38264543 | Synthetic Biology: Applications in the Food Sector |
| Q39414517 | Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, Clinical application, Adverse reactions and Outlook. |
Search more.